neogene.comHealthcareFounded: 2018Funding to Date: $125MM
Neogene Therapeutics develops personalized engineered T cell therapies for a broad spectrum of cancers.
For more details on financing and valuation for Neogene Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Neogene Therapeutics.
To read this article and more news on Neogene Therapeutics, register or login.
